The Best Way to Play 2016's Multibillion-Dollar "Blockbuster" Drugs

In the big-cap pharma arena, any drug that can ring up $1 billion in sales in its first 12 to 18 months on the market is called a "blockbuster." These drugs are the Holy Grail of pharma investing at this level. Of course, it's no coincidence that it costs $1 billion to bring a drug through clinical trials and Food and Drug Administration approvals. So, if a blockbuster drug does pull in $1 billion in revenue the first year out, you're basically printing money every year after that. Let me show you the immense scale of the opportunity that's right in front of us today... In 2014, the top-selling drug on the planet was AbbVie Inc.'s Humira. It pulled in $12 billion in sales. Gilead Sciences Inc.'s radical hepatitis C (HCV) drug, Sovaldi, brought in more than $10 billion, and the company's Harvoni sold $10 billion in its first year out of the gate. These are great drugs, and good profits, to be sure. But what's coming this year is going to be something else again... Tags: 2016 blockbuster drugs , blockbuster drugs , pharma investing To get full access to all Money Morning content, click here About Money Morning: Money Morning gives you access to a team of ten market experts with more than 250 years of combined investing experience – for free . Our experts – who have appeared on FOXBusiness, CNBC, NPR, and BloombergTV – deliver daily investing tips and stock picks, provide analysis with actions to take, and answer your biggest market questions. Our goal is to help our millions of e-newsletter subscribers and Moneymorning.com visitors become smarter, more confident investors. Disclaimer: © 2016 Money Morning and Money Map Press. All Rights Reserved. Protected by copyright of the United States and international treaties. Any reproduction, copying, or redistribution (electronic or otherwise, including the world wide web), of content from this webpage, in whole or in part, is strictly prohibited without the express written permission of Money Morning. 16 W. Madison St. Baltimore, MD, 21201. The post The Best Way to Play 2016's Multibillion-Dollar "Blockbuster" Drugs appeared first on Money Morning - We Make Investing Profitable .